Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea [2]

International Journal of STD and AIDS

Volumn 16, Issue 1, 2005, Pages 84-

  Waters, Laura J ^a   Boag, Fiona C ^a   Betournay, Richard ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; OFLOXACIN; PENICILLIN DERIVATIVE; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DOSE RESPONSE; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; GONORRHEA; HEALTH PROGRAM; HUMAN; LETTER; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE;

EID: 13244291755     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462052932746     Document Type: Letter

References (5)

1. Habib AR, Fernando R. Efficacy of azithromycin 1 g single dose in the management of uncomplicated gonorrhoea. Int J STD AIDS 2004;15:240-2
2. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2002 Report. London: Health Protection Agency, 2003
3. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2000 Report. London: Public Health Laboratory Service, 2001
4. GRASP Steering Group. The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) Year 2001 Report. London: Public Health Laboratory Service, 2002
5. Bignell C. National guidelines on the management of gonorrhoea in adults (draft) [www.bashh.org]